Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $16.01B. Across the group, the median move over the past trading day is +1.97%. Price change over the past year runs from −0.8% to +49.9% across the middle 80 percent of the group, with a median of +39.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GE9.DE | GENMAB AS N | 283.30 EUR | +10.97% | +5.71% | −14.41% |
| 0J9P.L | Incyte Corporation | $130.13 | +1.97% | +30.41% | +53.55% |
| IPN.PA | Ipsen S.A. | 162.60 EUR | +1.37% | +40.05% | +39.21% |
| 0IJO.L | Exelixis, Inc. | $56.16 | +3.33% | +30.00% | +44.33% |
| 0M2N.L | Orion Oyj | 80.50 EUR | +12.46% | +29.29% | +19.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.